Cargando…

Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept

BACKGROUND: Impact of recurrent pericarditis (RP) on patient health-related quality of life (HRQoL) was evaluated through qualitative patient interviews and as an exploratory endpoint in a Phase 2 trial evaluating the efficacy and safety of rilonacept (IL-1α/IL-1β cytokine trap) to treat RP. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, David, Klein, Allan, Cella, David, Beutler, Anna, Fang, Fang, Magestro, Matt, Cremer, Paul, LeWinter, Martin M., Luis, Sushil Allen, Abbate, Antonio, Ertel, Andrew, Litcher-Kelly, Leighann, Klooster, Brittany, Paolini, John F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061027/ https://www.ncbi.nlm.nih.gov/pubmed/33882846 http://dx.doi.org/10.1186/s12872-021-02008-3

Ejemplares similares

Interleukin‐1 Trap Rilonacept Improved Health‐Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY
por: Brucato, Antonio, et al.
Publicado: (2022)

Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial
por: Klein, Allan L, et al.
Publicado: (2021)

Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis
por: Brucato, Antonio, et al.
Publicado: (2023)

Rilonacept (Interleukin-1 Inhibition) for the Treatment of Pericarditis
por: Wang, Tom Kai Ming, et al.
Publicado: (2022)

Correction to: Rilonacept (Interleukin‑1 Inhibition) for the Treatment of Pericarditis
por: Wang, Tom Kai Ming, et al.
Publicado: (2022)

Rilonacept and Anakinra in Recurrent Pericarditis: A Systematic Review and Meta-Analysis
por: Affas, Ziad R, et al.
Publicado: (2022)

SARS-COV-2 AND MRNA VACCINE-ASSOCIATED RECURRENT PERICARDITIS TREATED WITH RILONACEPT
por: Shell, John Clark, et al.
Publicado: (2023)

Anti-interleukin-1 agents for pericarditis: a primer for cardiologists( )
por: Imazio, Massimo, et al.
Publicado: (2021)

US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis
por: Klein, Allan, et al.
Publicado: (2021)

Clinical Burden and Unmet Need in Recurrent Pericarditis: A Systematic Literature Review
por: Klein, Allan, et al.
Publicado: (2020)

Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population
por: Lin, David, et al.
Publicado: (2021)

Recurrent Pericarditis: a Stubborn Opponent Meets New Treatments in 2022
por: Hagerty, Tracy, et al.
Publicado: (2022)

Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS)
por: Gillespie, Justin, et al.
Publicado: (2010)

Lymphocytic Perimyocarditis Masquerading as Steroid-Dependent Recurrent Pericarditis
por: Dugan, Eunice S., et al.
Publicado: (2023)

Clinical Presentation and Outcomes of Acute Pericarditis in a Large Urban Hospital in the United States of America
por: Vecchié, Alessandra, et al.
Publicado: (2020)

Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis
por: Abadie, Bryan Q., et al.
Publicado: (2022)

Mysterious quad of constrictive pericarditis, recurrent pleural effusions, bone involvement and interstitial lung disease
por: Ding, Feihong, et al.
Publicado: (2019)

Inhibition of interleukin‐1 with rilonacept is not effective in cold urticaria—Results of a randomized, placebo‐controlled study
por: Bonnekoh, Hanna, et al.
Publicado: (2023)

Chronic calcific effusive constrictive pericarditis: a rare entity within the spectrum of pericardial diseases—a case report
por: Chetrit, Michael, et al.
Publicado: (2020)

Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap)
por: Church, Leigh D, et al.
Publicado: (2008)

The Effect of Rilonacept versus Placebo on Health-Related Quality of Life in Patients with Poorly Controlled Familial Mediterranean Fever
por: Hashkes, Philip J., et al.
Publicado: (2014)

Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator
por: Terkeltaub, Robert A, et al.
Publicado: (2013)

Emerging Therapies for Recurrent Pericarditis: Interleukin‐1 inhibitors
por: Lo Presti, Saberio, et al.
Publicado: (2021)

Complex Management Decisions in a Professional Athlete With Recurrent Pericarditis
por: Klein, Benjamin M., et al.
Publicado: (2022)

Acute pericarditis after atrial fibrillation ablation: Incidence, characteristics, and risk factors
por: Nakhla, Shady, et al.
Publicado: (2022)

The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches
por: Mauro, Adolfo G., et al.
Publicado: (2021)

Pericarditis and Sacroiliitis in a World Traveler
por: Vecchié, Alessandra, et al.
Publicado: (2021)

The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review
por: Baskar, Shankar, et al.
Publicado: (2016)

Determining Severity Strata for Three Atopic Dermatitis Patient-Reported Outcome Questionnaires: Defining Severity Score Ranges for the Worst Pruritus Numerical Rating Scale and the Atopic Dermatitis Symptom and Impact Scales (ADerm-SS and ADerm-IS)
por: Silverberg, Jonathan I., et al.
Publicado: (2022)

A Malignant Case of Constrictive Pericarditis
por: Betancor, Jorge, et al.
Publicado: (2017)

Refractory Recurrent Pericarditis After Pericardiectomy in a Young Woman
por: Lak, Hassan Mehmood, et al.
Publicado: (2021)

An Unusual Case of Parasitic Constrictive Pericarditis
por: Agrawal, Ankit, et al.
Publicado: (2023)

Inflamed Colon and Pericardium: A Rare Combination of Colitis and Recurrent Pericarditis
por: Kumar, Ashwin K., et al.
Publicado: (2021)

Content validity of the National Comprehensive Cancer Network – Functional Assessment of Cancer Therapy – Breast Cancer Symptom Index (NFBSI-16) and Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form with advanced breast cancer patients
por: Krohe, Meaghan, et al.
Publicado: (2019)

Recurrent pericarditis after Covid-19()
por: Rodrigo Domínguez, David, et al.
Publicado: (2022)

Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
por: Galipeau, Nina, et al.
Publicado: (2019)

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
por: Hashkes, PJ, et al.
Publicado: (2011)

Determinants of Passive Myocardial Stiffness Along the Spectrum of Aortic Stenosis
por: LeWinter, Martin M.
Publicado: (2018)

Recurrent Pericarditis in Children and Adolescents
por: Tombetti, Enrico, et al.
Publicado: (2019)

Pericarditis
Publicado: (1833)

Cannot write session to /tmp/vufind_sessions/sess_8bmgehjm7l8jpk7m5gsqtiis1l